UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 376

Sortiert nach

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

Molecular cancer therapeutics, 2016-10, Vol.15 (10), p.2273-2281

2016

Volltextzugriff (PDF)

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Cancer discovery, 2016-01, Vol.6 (1), p.96-107

2016

Volltextzugriff (PDF)

Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions

Cancers, 2016-09, Vol.8 (9), p.83

2016

Volltextzugriff (PDF)

Oral cancer in a 5-year-old boy: a rare case report and review of literature

Oral surgery, oral medicine, oral pathology and oral radiology, 2020-07, Vol.130 (1), p.e10-e19

2020

Volltextzugriff (PDF)

ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2

The EMBO journal, 2006-11, Vol.25 (22), p.5270-5283

2006

Volltextzugriff (PDF)

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.710-719

2012

Volltextzugriff (PDF)

[11C]PBR28 PET Imaging is Sensitive to Neuroinflammation in the Aged Rat

Journal of cerebral blood flow and metabolism, 2015-08, Vol.35 (8), p.1331-1338

2015

Volltextzugriff (PDF)

A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation

PloS one, 2012-06, Vol.7 (6), p.e39653

2012

Volltextzugriff (PDF)

Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment

Genomics (San Diego, Calif.), 2013-09, Vol.102 (3), p.157-162

2013

Volltextzugriff (PDF)

Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation

Developmental dynamics, 2012-02, Vol.241 (2), p.303-314

2012

Volltextzugriff (PDF)

Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells

Metabolites, 2019-01, Vol.9 (1), p.7

2019

Volltextzugriff (PDF)

Fibulin-1 Acts as a Cofactor for the Matrix Metalloprotease ADAMTS-1

The Journal of biological chemistry, 2005-10, Vol.280 (41), p.34796-34804

2005

Volltextzugriff (PDF)

Discovery of a Novel B-Raf Fusion Protein Related to c-Met Drug Resistance

Journal of proteome research, 2011-11, Vol.10 (11), p.5084-5094

2011

Volltextzugriff (PDF)

Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer

Frontiers in pharmacology, 2013-01, Vol.4, p.22-22

2013

Volltextzugriff (PDF)

Endocardial Brg1 Represses ADAMTS1 to Maintain the Microenvironment for Myocardial Morphogenesis

Developmental cell, 2008-02, Vol.14 (2), p.298-311

2008

Volltextzugriff (PDF)

Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models

Clinical cancer research, 2012-09, Vol.18 (18), p.5008-5019

2012

Volltextzugriff (PDF)

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)

Molecular cancer therapeutics, 2013-12, Vol.12 (12), p.2929-2939

2013

Volltextzugriff (PDF)

Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR

Science signaling, 2014-11, Vol.7 (351), p.ra107

2014

Volltextzugriff (PDF)

Clinicopathologic Case 2: Multiple Intraoral White Lesions in a 55-year-old Female

Oral surgery, oral medicine, oral pathology and oral radiology, 2024-05, Vol.137 (5), p.e101-e104

2024

Volltextzugriff (PDF)

Correction: A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation

PloS one, 2012-08, Vol.7 (8)

2012

Volltextzugriff (PDF)

Abstract 1444: TPX-0022, a potent MET/SRC/CSF1R inhibitor that modulates the tumor immune microenvironment in preclinical models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1444-1444

2021

Volltextzugriff (PDF)

Abstract 1104: Repotrectinib increases effectiveness of MEK inhibitors in KRAS mutant cancer models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1104-1104

2021

Volltextzugriff (PDF)

A Simple Method of Managing the Alveolar Antral Artery during Sinus Lift Surgery

International journal of otolaryngology and head & neck surgery, 2021, Vol.10 (3), p.131-146

2021

Volltextzugriff (PDF)

Abstract 330: Engineering electrophile-sensitive kinase mutants to accelerate oncology target validation

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.330-330

2021

Volltextzugriff (PDF)

A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation

PloS one, 2012, Vol.7 (6), p.e39653-e39653

2012

Volltextzugriff (PDF)

1 – 25 von 376

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(343)
Mit Volltextzugriff
(322)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(260)
Life Sciences & Biomedicine
(199)
Humans
(167)
Female
(76)
Male
(76)
Adult
(51)
Middle Aged
(49)
Aged
(42)
Animals
(41)
Biological And Medical Sciences
(40)
General & Internal Medicine
(37)
Physical Sciences
(33)
Medicine, General & Internal
(32)
Medical Sciences
(30)
Technology
(28)
Mice
(25)
Risk Factors
(24)
Aged, 80 And Over
(23)
Science & Technology - Other Topics
(23)
Biochemistry & Molecular Biology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions

Oral cancer in a 5-year-old boy: a rare case report and review of literature

ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735

[11C]PBR28 PET Imaging is Sensitive to Neuroinflammation in the Aged Rat

A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation

Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment

Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation

Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells

Fibulin-1 Acts as a Cofactor for the Matrix Metalloprotease ADAMTS-1

Discovery of a Novel B-Raf Fusion Protein Related to c-Met Drug Resistance

Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer

Endocardial Brg1 Represses ADAMTS1 to Maintain the Microenvironment for Myocardial Morphogenesis

Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)

Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR

Clinicopathologic Case 2: Multiple Intraoral White Lesions in a 55-year-old Female

Correction: A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation

Abstract 1444: TPX-0022, a potent MET/SRC/CSF1R inhibitor that modulates the tumor immune microenvironment in preclinical models

Abstract 1104: Repotrectinib increases effectiveness of MEK inhibitors in KRAS mutant cancer models

A Simple Method of Managing the Alveolar Antral Artery during Sinus Lift Surgery

Abstract 330: Engineering electrophile-sensitive kinase mutants to accelerate oncology target validation

A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation

Suchergebnisse filtern